MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

Veriheal

JANUARY 7, 2022

After the 2019 vape crisis that resulted in at least 68 deaths across the U.S., Based on the study’s data, the use of cannabis among 12th graders over the last several years has consistently remained around the 35% mark. Cannabis is a natural medicine that is legal in over half of the U.S. and Canada. for medical purposes.

Vaping 98

Vaping Education Data Consumption 98

Cannabis Law Report

MAY 12, 2022

Back in 2019, the UK loosened their rules around medical cannabis and allowed a handful of cannabis-derived drugs to be prescribed. Still, only a small number of patients actually get medical cannabis prescriptions and accessibility is still a hot button issue in the country.

Terpenes 52

Terpenes Extraction Advocacy Patients 52

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. In 2019, the island’s economy grew by 2.1% has emerged as the largest supplier of medicinal cannabis in the world. in real terms to £4.97

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

JUNE 26, 2019

Minister for Health Simon Harris TD today signed legislation which will allow for the operation of the Medical Cannabis Access Programme on a pilot basis for five years. The Programme will facilitate access to cannabis-based products for medical use in line with legislation. Further information on the Medical Cannabis Access Programme.

Medicine 55

Medicine Access Business Legislation 55

SpeedWeed

AUGUST 22, 2021

A report released by the MS Society states that not nearly enough medical cannabis patients have been able to obtain medical cannabis through the National Health Service (NHS), despite research and firsthand accounts of its effectiveness as a medicine for MS patients. deserves access to effective?treatments.” treatments.” .

Sleep 52

Sleep Access Patients Treatment 52

Cannabis Law Report

FEBRUARY 12, 2020

Dr Winlow told AAP that companies have been putting too much effort into growing pot and not enough into proving the drug is a safe and effective medicine. “What these companies have failed to do is penetrate mainstream medicine.” In fiscal 2019 it had a loss of $5.5

Medicine 59

Medicine Data Patients Oil 59

Cannabis Law Report

NOVEMBER 3, 2021

Khiron in the United Kingdom The company is pursuing a consistent approach to improve patient access to medical cannabis and to develop the market for medical cannabis treatments in the UK. Both virtual and in-person appointments can be made via the website www.zereniaclinic.co.uk.

Therapy 52

Therapy Access Patients Treatment 52

Cannabis Law Report

FEBRUARY 14, 2020

million in tax revenue and licensing fees in 2019, far outpacing the US $1.8 million projected after the legalization of cannabis cultivation and sales for medicinal purposes in December 2018. Only US $2.2

Banking 59

Banking Medicine Data Cultivation 59

Veriheal

MARCH 23, 2023

The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. 124’—the use and application of medicines manufactured from “marijuana” to any person are currently prohibited.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

The Cannigma

FEBRUARY 2, 2021

As medicinal cannabis treatments are now legal in many parts of the world, naturally, there is a growing interest in whether the products can treat neurological conditions like Parkinson’s disease. Patients can also access CBD products without a prescription through local pharmacies. Parkinson’s disease and cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

SpeedWeed

MAY 25, 2021

Researchers collected data from the 2019-2020 National Health and Resilience in Veterans Study, a national survey that asks veterans to self-report their physical and mental health as well as their recent substance use. An analysis of the survey data revealed that 11.9 View original article.

Chronic Pain 52

Chronic Pain Marijuana Data Programs 52

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. Results highlight the need for expanded patient access to CBD products.”. CBD for hypertension.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

SpeedWeed

AUGUST 31, 2021

16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. 6, 2019, and Dec. 6, 2019, and Dec. The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate.

Programs 72

Programs Patients Dispensary Cultivation 72

Cannabis Law Report

NOVEMBER 14, 2019

Australia’s westernmost state is making it easier for patients to access medical cannabis. When considering many using medicinal cannabis products have serious illnesses and are sometimes financially strained, the previous access regime unnecessarily added a number of months and additional costs to the process.”

Patients 45

Patients Access Medicine Pharmaceutical 45

Veriheal

JULY 12, 2021

Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? Veterans with PTSD can expect to benefit from the medicinal benefits in terms of alleviating symptoms.

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

SEPTEMBER 11, 2019

FreshLeaf Analytics say they have released Australia’s most comprehensive medicinal cannabis Patient , Product and Pricing Analysis. Medicinal cannabis may be legal but obtaining it has been an exercise in the absurd. He was unaware of medicinal cannabis and so had to be educated. Freshleaf-Q3-2019-Report.

Research and Development 45

Research and Development Medicine Patients Pharmaceutical 45

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. Results highlight the need for expanded patient access to CBD products.”. CBD for hypertension.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

SpeedWeed

AUGUST 31, 2021

16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. 6, 2019, and Dec. 6, 2019, and Dec. The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate.

Consumption 57

Consumption Programs Patients Dispensary 57

SpeedWeed

AUGUST 31, 2021

16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. 6, 2019, and Dec. 6, 2019, and Dec. The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate.

Agriculture 53

Agriculture Programs Patients Dispensary 53

Cannabis Law Report

NOVEMBER 6, 2019

5, 2019) — ValidCare, the hemp industry’s leading market intelligence and consumer research platform, and the University of Kentucky Research Foundation (UKRF) have announced they have entered into a services agreement to advance the research of hemp-derived products. LEXINGTON, Ky. About ValidCare.

Hemp 45

Hemp Data Access Education 45

SpeedWeed

SEPTEMBER 1, 2021

16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. 6, 2019, and Dec. 6, 2019, and Dec. The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate.

Programs 52

Programs Patients Dispensary Cultivation 52

Cannabis Law Report

JANUARY 23, 2022

Events like these afford us a glimpse into the future of research and medicine in this field. One presentation was particularly powerful in framing the value that this new realm of research could bring to modern medicine, and I shall share that study with you today. The grading of GVHD (Holler, Greinix and Zeiser, 2019).

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

Cannabis Law Report

JULY 24, 2022

The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 Psychedelics, unless they serve as an active ingredient of an approved medicinal product ( note : currently no such medicinal product is approved; cf. ruling BVGer C-4592/2019).

Research and Development 52

Research and Development Legalization Treatment Patients 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). Published 2019 May 6.

Patients 98

Patients Education Marijuana Therapy 98

PrestoDoctor

SEPTEMBER 6, 2023

One of the primary reasons for this shift is the growing acceptance and accessibility of cannabis as an alternative pain management option. In regions where medical cannabis is accessible, some studies have shown a decrease in opioid prescriptions and opioid-related fatalities.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Cannabis Law Report

JULY 6, 2021

In 2019, Dr. Johnson received the R. Brinkley Smithers award from the American Association of Addiction Medicine. The opportunity exists to meld our evolving understanding of the biological mechanisms underlying addiction with the personalized psycho-spiritual approach being realized by psychedelic medicine.”

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. A 2019 study found that 76% of patients in the U.S. Findings from the CDC’s 2019 National Health Interview Survey report that 20.4% The Opioid Problem. More Telemedicine.

Programs 52

Programs Chronic Pain Treatment Conditions 52

CannaTech

MAY 16, 2019

CannaTech Tel Aviv 2019 was an absolute sensation, and we are already looking to Cape Town for our next big event. This revolutionary storage device maintains optimal conditions for cannabis freshness and potency, and makes monitoring, tracking, dispensing, and procuring medical cannabis accessible to everyday patients.

Data 13

Data Collective Consumption Treatment 13

Kind Meds (Cannabis Education Blog)

MARCH 9, 2022

Kansas journal of medicine, 13, 129–130. By getting a medical card, you will be able to access marijuana for medical purposes. Cannabis use, employment, and income: fixed-effects analysis of panel data. 1] Burggren, A. Shirazi, A., Ginder, N., & London, E. 2] Emoto, J., Weeks, K., & Kallail, K. 3] Feingold, D.,

Digestion 98

Digestion Consumption Cannabis Recreational 98

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

MAY 29, 2022

In May 2021, a Nature Medicine study showed the benefits of MDMA in relieving post-traumatic stress disorder. [4] 4] In April 2021, a separate study from the New England Journal of Medicine demonstrated the efficacy of psilocybin in reducing symptoms of depression. [5] and Seattle, among other municipalities.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

SpeedWeed

MAY 22, 2021

This work builds capacity to deliver quality, accessible care to patients, pending approval of MDMA-assisted therapy as a legal prescription treatment.”. MAPS actually asked the FDA for permission to begin the trial back in 2019, but the agency chose to put the trial on a 20-month clinical hold.

Clinical Trials 52

Clinical Trials Therapy Legalization Research and Development 52

Healer

MARCH 26, 2021

Opioids are a good medicine. The results were published in the Cureus Journal of Medical Science, an open-access general medical journal known for its use of crowdsourcing in its peer-review process. . We have a lot less data on the use of cannabis as a treatment for opioid use disorder,” Sulak said. . WHAT ABOUT CBD?

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. These treatments can be prescribed only by specialist doctors in a limited number of circumstances where other medicines have failed. September 23, 2019. What do experts say?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

WeedAdvisor

SEPTEMBER 26, 2019

By August of 2019, this practically doubled, hitting 83,000. According to Marijuana Business Daily : “Through the first eight months of 2019, sales of [medicinal marijuana] in the state totaled nearly $150 million – already topping sales recorded for the entirety of 2018 – and are on pace to break $240 million by the end of the year.”.

Recreational 45

Recreational Patients Programs History 45